•
Jun 30, 2021

Radnet Q2 2021 Earnings Report

RadNet reported record revenue and adjusted EBITDA for Q2 2021, driven by recovering procedural volumes and cost-containment measures.

Key Takeaways

RadNet, Inc. reported a strong financial performance for the second quarter of 2021, achieving record revenue of $333.9 million and adjusted EBITDA of $56.6 million. The company saw significant increases in MRI, CT, and PET/CT volumes, as well as overall volume, compared to the same period in 2020. RadNet also revised its 2021 guidance upwards, reflecting confidence in its business trends and financial performance.

RadNet set all-time quarterly records for Revenue and Adjusted EBITDA.

Revenue increased by 75.2% and Adjusted EBITDA increased by 150.7% compared to Q2 2020.

Adjusted diluted net income was $0.27 per share, compared to an adjusted net loss of $(0.14) per share in Q2 2020.

The company is deploying its DeepHealth AI mammography triage software nationwide.

Total Revenue
$334M
Previous year: $191M
+75.2%
EPS
$0.27
Previous year: -$0.16
-268.8%
Imaging centers
353
Previous year: 332
+6.3%
Gross Profit
$50.3M
Previous year: -$3.65M
-1479.0%
Cash and Equivalents
$141M
Previous year: $84.6M
+66.5%
Total Assets
$2.03B
Previous year: $1.72B
+18.4%

Radnet

Radnet

Forward Guidance

RadNet has increased guidance ranges for Revenue, Adjusted EBITDA and Free Cash Flow, and raised Capital Expenditures level to reflect additional investments in growth opportunities.